Recombinant Human IL20 Protein，His

IL-20, a member of the interleukin-10 (IL-10) family of cytokines, plays a crucial role in the regulation of immune responses and inflammation. It is primarily produced by activated macrophages and keratinocytes, and is involved in various physiological and pathological processes, including skin disorders such as psoriasis, atopic dermatitis, and inflammatory bowel diseases. The significance of IL-20 is underscored by its ability to promote keratinocyte proliferation and differentiation, as well as its involvement in the inflammatory pathways that can exacerbate chronic conditions. Given its pivotal role in mediating inflammatory responses, researchers have focused on recombinant IL-20 proteins to investigate their therapeutic potential. Developing recombinant IL-20 allows for studying its biological functions more extensively and exploring its role in disease mechanisms. Moreover, IL-20's interaction with its receptors, IL-20R1 and IL-20R2, opens avenues for targeted treatments aimed at modulating immune responses in various inflammatory diseases. Understanding the structure-function relationship of IL-20 through recombinant technology can lead to innovative strategies for developing new therapies that either inhibit its action to reduce inflammation or utilize its effects to promote wound healing. As research progresses, recombinant IL-20 is poised to play a significant role in advancing our approach to treating immune-mediated diseases and improving patient outcomes.